中国现代药物应用2024,Vol.18Issue(15) :67-69.DOI:10.14164/j.cnki.cn11-5581/r.2024.15.018

阿托伐他汀钙治疗急性脑梗死的效果与安全性分析

Analysis of the effect and safety of atorvastatin calcium in the treatment of acute cerebral infarction

冯桂贤
中国现代药物应用2024,Vol.18Issue(15) :67-69.DOI:10.14164/j.cnki.cn11-5581/r.2024.15.018

阿托伐他汀钙治疗急性脑梗死的效果与安全性分析

Analysis of the effect and safety of atorvastatin calcium in the treatment of acute cerebral infarction

冯桂贤1
扫码查看

作者信息

  • 1. 024005 赤峰松山医院神经内科
  • 折叠

摘要

目的 评价急性脑梗死(ACI)患者行阿托伐他汀钙治疗的预后效果及药物安全性.方法 选择 106 例ACI患者,以随机法分为对照组(n=53,采取辛伐他汀治疗)和观察组(n=53,采取阿托伐他汀钙片治疗).比较两组临床疗效、药物不良反应发生情况、神经功能缺损程度以及康复情况.结果 观察组治疗总有效率96.23%高于对照组的81.13%,差异显著(P<0.05).两组药物不良反应发生率比较,差异无统计学意义(P>0.05).两组治疗后美国国立卫生研究院卒中量表(NIHSS)评分均较治疗前低,且观察组NIHSS评分(4.55±1.20)分低于对照组的(5.60±1.40)分,差异显著(P<0.05).两组治疗后氧化型低密度脂蛋白(ox-LDL)、超敏C反应蛋白(hs-CRP)水平均低于治疗前,且观察组治疗后ox-LDL(46.78±4.45)μg/dl、hs-CRP(3.22±1.01)mg/L均低于对照组的(57.32±4.55)μg/dl、(8.72±1.20)mg/L,差异显著(P<0.05).结论 阿托伐他汀钙片治疗ACI具有安全性、有效性,能促进患者神经功能改善、临床恢复.

Abstract

Objective To evaluate the prognostic effect and safety of atorvastatin calcium in the treatment of acute cerebral infarction(ACI).Methods 106 ACI patients were selected and randomly divided into a control group(n=53,treated with simvastatin)and an observation group(n=53,treated with atorvastatin calcium tablets).The clinical efficacy,adverse drug reactions,degree of neurological impairment,and rehabilitation were compared between the two groups.Results The total effective rate of the observation group was 96.23%,which was higher than 81.13%of control group,and the difference was significant(P<0.05).There was no significant difference in the incidence of adverse drug reactions between the two groups(P>0.05).After treatment,the National Institutes of Health Stroke Scale(NIHSS)score in both groups was lower than that before treatment,and the NIHSS score of(4.55±1.20)points in the observation group was lower than(5.60±1.40)points in the control group.The difference was significant(P<0.05).After treatment,the levels of oxidized low-density lipoprotein(ox-LDL)and hypersensitive C-reactive protein(hs-CRP)in both groups were lower than those before treatment;the observation group had ox-LDL of(46.78±4.45)μg/dl and hs-CRP of(3.22±1.01)mg/L,which were lower than(57.32±4.55)μg/dl and(8.72±1.20)mg/L in the control group;the difference was significant(P<0.05).Conclusion Atorvastatin calcium tablets are safe and effective in the treatment of ACI,and can promote the improvement of neurological function and clinical recovery in patients.

关键词

阿托伐他汀钙片/急性脑梗死/神经功能/不良反应/效果

Key words

Atorvastatin calcium/Acute cerebral infarction/Neurological function/Adverse reactions/Effect

引用本文复制引用

出版年

2024
中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
段落导航相关论文